Analyst Recommendations

Bernstein analyst issues UNDERPERFORM recommendation for ARM on October 31, 2024 04:46AM ET. The previous analyst recommendation was Market Perform.ARM was trading at $154.4 at issue of the...

October 31, 2024   ARM -2.80%

DNB Markets analyst issues HOLD recommendation for SPXXF on October 31, 2024 04:58AM ET. SPXXF was trading at $7.78 at issue of the analyst recommendation.
Historical Analyst Recommendations
Latest 10...

October 31, 2024   ARM -2.80%

Guggenheim analyst issues NEUTRAL recommendation for GSK on October 31, 2024 05:02AM ET. The previous analyst recommendation was Buy.GSK was trading at $37.01 at issue of the analyst...

October 31, 2024   GSK 0.89%

Santander analyst issues OUTPERFORM recommendation for JRONY on October 31, 2024 05:00AM ET. JRONY was trading at $37.66 at issue of the analyst recommendation.The overall analyst consensus :...

October 31, 2024   JRONY 1.17%

HSBC analyst issues REDUCE recommendation for TEL on October 31, 2024 04:59AM ET. The previous analyst recommendation was Hold.TEL was trading at $151.79 at issue of the analyst...

October 31, 2024   TEL 0.43%

HSBC analyst issues HOLD recommendation for TT on October 31, 2024 04:59AM ET. The previous analyst recommendation was Buy.TT was trading at $375.52 at issue of the analyst...

October 31, 2024   TT -0.65%

RBC Capital analyst issues OUTPERFORM recommendation for ATZAF on October 31, 2024 03:03AM ET. The previous analyst recommendation was Sector Perform.ATZAF was trading at $32.15 at issue of...

October 31, 2024   ATZAF 1.22%

William Blair analyst issues MARKET PERFORM recommendation for ALTR on October 31, 2024 03:00AM ET. The previous analyst recommendation was Buy.ALTR was trading at $108.63 at issue of...

October 31, 2024   ALTR 0.06%

Oppenheimer analyst issues OUTPERFORM recommendation for KLAC on October 31, 2024 02:58AM ET. The previous analyst recommendation was Perform.KLAC was trading at $691.8 at issue of the analyst...

October 31, 2024   KLAC -0.33%

Santander analyst issues OUTPERFORM recommendation for BRFS on October 30, 2024 09:22PM ET. BRFS was trading at $4.47 at issue of the analyst recommendation.The overall analyst consensus :...

October 30, 2024   BRFS -1.65%